dc.contributor.author | Zuwawa, Salheen | |
dc.date.accessioned | 2019-04-20T10:28:21Z | |
dc.date.available | 2019-04-20T10:28:21Z | |
dc.date.issued | 2018-04-13 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/692 | |
dc.description | Osteoporosis is a major cause of morbidity and mortality in older people. Calcium supplements
marginally reduce the risk of fracture[2], and most guidelines recommend adequate calcium intake
as an integral part of the prevention or treatment of osteoporosis[3]. Consequently, calcium
supplements are commonly used by people over the age of. Observational studies suggest that high
calcium intake might protect against vascular disease[4], and the findings are consistent with those
of interventional studies of calcium supplements that show improvement in some vascular risk
factors. In contrast, calcium supplements accelerate vascular calcification and increase mortality
in patients with renal failure, in both dialysis and predialysis populations[5]. Furthermore, a five
year randomized controlled trial of calcium supplements in healthy older women, in which
cardiovascular events were prespecified as secondary end points, recently reported possible
increases in rates of myocardial infarction and cardiovascular events in women allocated to
calcium. We carried out a meta-analysis of cardiovascular events in randomised trials of calcium
supplements. | en_US |
dc.description.abstract | In this report we will be discussing the effect of calcium supplements on risk of myocardial
infarction and cardiovascular events, 15 studies were included. Overall, 190 potentially relevant
reports of studies were identified from the initial searches, but only the 15 studies were eligible for
analysis. Thirteen studies compared calcium supplements with placebo, one study had a 2×2
factorial design allowing comparison of calcium with placebo and calcium plus vitamin D with
vitamin D,28 and one study compared calcium plus alendronate with alendronate. | en_US |
dc.language.iso | en | en_US |
dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Effect of calcium supplements on risk of myocardial infarction and cardiovascular events | en_US |
dc.type | Other | en_US |